Larson Financial Group LLC

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1731061 ST LOUIS, MO

Position in TAK

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$143,696

+$34,566 QoQ

Shares Held

7,759

+10.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Larson Financial Group LLC holds $2,020,512 across 41 Drug Manufacturers - Specialty & Generic names. TAK ranks #3 (7.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	6,129	$724,509
2	NBIX	Neurocrine Biosciences Inc	1,542	$203,143
3	TAK	Takeda Pharmaceutical Co Ltd This page	7,759	$143,696
4	HIMS	Hims & Hers Health, Inc.	6,697	$139,029
5	HLN	Haleon plc	12,224	$122,362
6	LNTH	Lantheus Holdings, Inc.	1,453	$110,210
7	UTHR	UNITED THERAPEUTICS Corp	181	$107,329
8	HROW	Harrow, Inc.	2,277	$80,287

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$143,696	7,759	+10.8%	Shares	Sole	2026-05-15
2025-12-31	$109,130	7,000	-10.5%	Shares	Sole	2026-02-06
2025-09-30	$114,528	7,823	+43.7%	Shares	Sole	2025-11-14
2025-06-30	$84,164	5,444	-0.4%	Shares	Sole	2025-08-08
2025-03-31	$81,309	5,468	+10.0%	Shares	Sole	2025-05-02
2024-12-31	$65,829	4,972	0.0%	Shares	Sole	2025-02-07
2024-09-30	$70,701	4,972	+10.8%	Shares	Sole	2024-11-12
2024-06-30	$58,061	4,487	0.0%	Shares	Sole	2024-08-02
2024-03-31	$62,324	4,487	-45.0%	Shares	Sole	2024-05-03
2023-12-31	$116,471	8,162	+1890.7%	Shares	Sole	2024-02-01
2022-03-31	$5,871	410	0.0%	Shares	Sole	2022-05-05
2021-12-31	$5,588	410	+2.5%	Shares	Sole	2022-02-03
2021-09-30	$6,552	400	0.0%	Shares	Sole	2021-11-04
2021-06-30	$6,732	400	—	Shares	Sole	2021-08-10
No filing history on record for this holder in this stock.